IL254423D0 - Immunomodulators - Google Patents

Immunomodulators

Info

Publication number
IL254423D0
IL254423D0 IL254423A IL25442317A IL254423D0 IL 254423 D0 IL254423 D0 IL 254423D0 IL 254423 A IL254423 A IL 254423A IL 25442317 A IL25442317 A IL 25442317A IL 254423 D0 IL254423 D0 IL 254423D0
Authority
IL
Israel
Prior art keywords
immunomodulators
Prior art date
Application number
IL254423A
Other languages
Hebrew (he)
Inventor
Kenneth M Boy
Li-Qiang Sun
Qian Zhao
Eric Mull
Eric P Gillis
Paul Michael Scola
Original Assignee
Squibb Bristol Myers Co
Kenneth M Boy
Sun Li Qiang
Qian Zhao
Eric Mull
Eric P Gillis
Paul Michael Scola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201562134686P priority Critical
Priority to PCT/US2016/022619 priority patent/WO2016149351A1/en
Application filed by Squibb Bristol Myers Co, Kenneth M Boy, Sun Li Qiang, Qian Zhao, Eric Mull, Eric P Gillis, Paul Michael Scola filed Critical Squibb Bristol Myers Co
Publication of IL254423D0 publication Critical patent/IL254423D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
IL254423A 2015-03-18 2017-09-11 Immunomodulators IL254423D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201562134686P true 2015-03-18 2015-03-18
PCT/US2016/022619 WO2016149351A1 (en) 2015-03-18 2016-03-16 Immunomodulators

Publications (1)

Publication Number Publication Date
IL254423D0 true IL254423D0 (en) 2017-11-30

Family

ID=55642894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL254423A IL254423D0 (en) 2015-03-18 2017-09-11 Immunomodulators

Country Status (15)

Country Link
US (1) US9809625B2 (en)
EP (1) EP3271373A1 (en)
JP (1) JP2018511590A (en)
KR (1) KR20170128489A (en)
CN (1) CN107428804A (en)
AR (1) AR103969A1 (en)
AU (1) AU2016233292A1 (en)
BR (1) BR112017019591A2 (en)
CA (1) CA2980147A1 (en)
EA (1) EA033739B1 (en)
IL (1) IL254423D0 (en)
MX (1) MX2017011960A (en)
SG (1) SG11201707479YA (en)
TW (1) TW201702259A (en)
WO (1) WO2016149351A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732119B2 (en) 2014-10-10 2017-08-15 Bristol-Myers Squibb Company Immunomodulators
US9856292B2 (en) 2014-11-14 2018-01-02 Bristol-Myers Squibb Company Immunomodulators
US9861680B2 (en) 2014-12-18 2018-01-09 Bristol-Myers Squibb Company Immunomodulators
US9944678B2 (en) 2014-12-19 2018-04-17 Bristol-Myers Squibb Company Immunomodulators
US20160222060A1 (en) 2015-02-04 2016-08-04 Bristol-Myers Squibb Company Immunomodulators
US9809625B2 (en) 2015-03-18 2017-11-07 Bristol-Myers Squibb Company Immunomodulators
US10143746B2 (en) 2016-03-04 2018-12-04 Bristol-Myers Squibb Company Immunomodulators
US10358463B2 (en) 2016-04-05 2019-07-23 Bristol-Myers Squibb Company Immunomodulators
TW201740943A (en) 2016-05-11 2017-12-01 滬亞生物國際有限公司 Combination therapies of HDAC inhibitors and PD-1 inhibitors
TW201808286A (en) 2016-05-11 2018-03-16 滬亞生物國際有限公司 Combination therapies of HDAC inhibitors and PD-L1 inhibitors
KR20190075118A (en) * 2016-11-07 2019-06-28 브리스톨-마이어스 스큅 컴퍼니 Immunomodulator
US20190292187A1 (en) 2018-02-26 2019-09-26 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
WO2019195181A1 (en) 2018-04-05 2019-10-10 Gilead Sciences, Inc. Antibodies and fragments thereof that bind hepatitis b virus protein x
WO2019193533A1 (en) 2018-04-06 2019-10-10 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'2'-cyclic dinucleotides
US20190322696A1 (en) 2018-04-06 2019-10-24 Institute of Organic Chemistry and Biochemistry, ASCR, V.V.I 3'3'-cyclic dinucleotides
WO2019193542A1 (en) 2018-04-06 2019-10-10 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'3'-cyclic dinucleotides
US20190338263A1 (en) 2018-04-12 2019-11-07 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
WO2019211799A1 (en) 2018-05-03 2019-11-07 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
MX9203291A (en) 1985-06-26 1992-08-01 Liposome Co Inc Method for coupling liposomes.
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US6410690B1 (en) 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5811097A (en) 1995-07-25 1998-09-22 The Regents Of The University Of California Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
US5922845A (en) 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
US6277818B1 (en) 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
US7521051B2 (en) 2002-12-23 2009-04-21 Medimmune Limited Methods of upmodulating adaptive immune response using anti-PD-1 antibodies
EP2161336B2 (en) 2005-05-09 2017-03-29 ONO Pharmaceutical Co., Ltd. Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
WO2007005874A2 (en) 2005-07-01 2007-01-11 Medarex, Inc. Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
EP2990411B1 (en) 2007-03-26 2017-05-03 The University of Tokyo Process for synthesizing cyclic peptide compound
WO2009114335A2 (en) 2008-03-12 2009-09-17 Merck & Co., Inc. Pd-1 binding proteins
JP2012500855A (en) 2008-08-25 2012-01-12 アンプリミューン、インコーポレーテッドAmplimmune, Inc. PD-1 antagonists and methods for treating infectious diseases
US8907053B2 (en) 2010-06-25 2014-12-09 Aurigene Discovery Technologies Limited Immunosuppression modulating compounds
JP5818237B2 (en) 2010-09-09 2015-11-18 国立大学法人 東京大学 Translational construction and search for active species of special peptide compound library containing N-methylamino acid and other special amino acids
US10195578B2 (en) 2010-12-03 2019-02-05 The University Of Tokyo Peptide library production method, peptide library, and screening method
US9096642B2 (en) 2011-06-08 2015-08-04 Aurigene Discovery Technologies Limited Therapeutic compounds for immunomodulation
JP2015512910A (en) 2012-03-29 2015-04-30 オーリジーン ディスカバリー テクノロジーズ リミテッドAurigene Discovery Technologies Limited Immunomodulatory cyclic compounds derived from the BC loop of human PD1
JP2013253842A (en) 2012-06-06 2013-12-19 Univ Of Tokyo Screening method for peptide connected to target molecule depending on ph
CN104603145B (en) 2012-06-06 2018-05-18 波利弗尔股份公司 β-hairpin peptidomimetics
US9308236B2 (en) 2013-03-15 2016-04-12 Bristol-Myers Squibb Company Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
AU2014235453A1 (en) 2013-03-15 2015-10-08 Genentech, Inc. Biomarkers and methods of treating PD-1 and PD-L1 related conditions
PL3041468T3 (en) 2013-09-06 2018-12-31 Aurigene Discovery Technologies Limited Cyclic peptidomimetic compounds as immunomodulators
WO2015044900A1 (en) 2013-09-27 2015-04-02 Aurigene Discovery Technologies Limited Therapeutic immunomodulating compounds
WO2016039749A1 (en) 2014-09-11 2016-03-17 Bristol-Myers Squibb Company Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions
US9732119B2 (en) 2014-10-10 2017-08-15 Bristol-Myers Squibb Company Immunomodulators
US9856292B2 (en) 2014-11-14 2018-01-02 Bristol-Myers Squibb Company Immunomodulators
US9861680B2 (en) 2014-12-18 2018-01-09 Bristol-Myers Squibb Company Immunomodulators
US9944678B2 (en) 2014-12-19 2018-04-17 Bristol-Myers Squibb Company Immunomodulators
US20160222060A1 (en) 2015-02-04 2016-08-04 Bristol-Myers Squibb Company Immunomodulators
US9809625B2 (en) 2015-03-18 2017-11-07 Bristol-Myers Squibb Company Immunomodulators

Also Published As

Publication number Publication date
KR20170128489A (en) 2017-11-22
CA2980147A1 (en) 2016-09-22
AU2016233292A1 (en) 2017-11-09
TW201702259A (en) 2017-01-16
EP3271373A1 (en) 2018-01-24
MX2017011960A (en) 2018-02-09
EA033739B1 (en) 2019-11-21
BR112017019591A2 (en) 2018-05-02
US20160272680A1 (en) 2016-09-22
US9809625B2 (en) 2017-11-07
WO2016149351A1 (en) 2016-09-22
AR103969A1 (en) 2017-06-14
CN107428804A (en) 2017-12-01
JP2018511590A (en) 2018-04-26
EA201791739A1 (en) 2018-01-31
SG11201707479YA (en) 2017-10-30

Similar Documents

Publication Publication Date Title
IL258607D0 (en) Compounds useful as immunomodulators
DK3233887T3 (en) immunomodulators
IL252853D0 (en) Immunomodulators
EA033739B1 (en) Immunomodulators
SG11201702792SA (en) Immunomodulators
IL253745D0 (en) Immunomodulators
GB201404893D0 (en) Selfie - Stick
AU361515S (en) Dishrack
IL254030D0 (en) שימוש בפרידופידין לשיפור תפקוד קוגניטיבי ולטיפול במחלת אלצהיימר
GB201412117D0 (en) Soundbar
GB201514938D0 (en) Braring calculation
IL255194D0 (en) Solid forms
GB201415825D0 (en) Multirotor
GB201514751D0 (en) Compounds
GB201514754D0 (en) Compounds
GB201707959D0 (en) No details
AU362944S (en) Lapboard
GB201409056D0 (en) Datacentre
GB201706130D0 (en) No details
GB201612542D0 (en) no details
IL261408D0 (en) Immunomodulators
GB201411713D0 (en) S-detekt
GB201510019D0 (en) Compounds
GB201509585D0 (en) -
GB201415937D0 (en) Biofumigant